Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 10.87
-0.21 (-1.90%)
May 20, 2026, 2:45 PM CST
SHE:301211 Market Cap
SHE:301211 has a market cap or net worth of 4.63 billion as of May 19, 2026. Its market cap has increased by 0.41% in one year.
Market Cap
4.63B
Enterprise Value
3.09B
Revenue
459.02M
Ranking
n/a
PE Ratio
138.50
Stock Price
10.87
Market Cap Chart
Since December 22, 2021, SHE:301211's market cap has decreased from 8.96B to 4.63B, a decrease of -48.34%. That is a compound annual growth rate of -13.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 4.63B | -9.33% |
| Dec 31, 2025 | 5.10B | -16.66% |
| Dec 31, 2024 | 6.12B | -2.25% |
| Dec 29, 2023 | 6.26B | -24.68% |
| Dec 30, 2022 | 8.32B | -7.87% |
| Dec 31, 2021 | 9.03B | 0.78% |
| Dec 22, 2021 | 8.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Yatai Pharmaceutical | 4.76B |
| Bide Pharmatech | 4.76B |
| Teyi Pharmaceutical Group Co.,Ltd | 4.75B |
| Zhongzhu Healthcare Holding Co.,Ltd | 4.75B |
| Fuan Pharmaceutical (Group) | 4.72B |
| Jianmin Pharmaceutical Group | 4.72B |
| Hunan Fangsheng Pharmaceutical | 4.70B |
| Nanjing Hicin Pharmaceutical | 4.63B |